Does ARIXTRA Cause Neoplasm malignant? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Neoplasm malignant have been filed in association with ARIXTRA. This represents 3.7% of all adverse event reports for ARIXTRA.
11
Reports of Neoplasm malignant with ARIXTRA
3.7%
of all ARIXTRA reports
8
Deaths
1
Hospitalizations
How Dangerous Is Neoplasm malignant From ARIXTRA?
Of the 11 reports, 8 (72.7%) resulted in death, 1 (9.1%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ARIXTRA. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does ARIXTRA Cause?
Death (37)
Investigation (33)
Haematoma (27)
Anaemia (20)
Incorrect drug administration duration (19)
Off label use (18)
Thrombosis (17)
Haemorrhage (13)
Cerebral haemorrhage (11)
Gastrointestinal haemorrhage (11)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which ARIXTRA Alternatives Have Lower Neoplasm malignant Risk?
ARIXTRA vs ARMODAFINIL
ARIXTRA vs AROMASIN
ARIXTRA vs ARSENIC TRIOXIDE
ARIXTRA vs ARTEMETHER\LUMEFANTRINE
ARIXTRA vs ARTESUNATE